Disclosures for "Effectiveness and Safety of Low-Sodium Oxybate in Participants With Narcolepsy or Idiopathic Hypersomnia: Top-line Results From the Phase 4 DUET Study"
-
Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.
-
David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences. David Plante has received personal compensation in the range of $0-$499 for serving as a Consultant for Aditum Bio. David Plante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. David Plante has received intellectual property interests from a discovery or technology relating to health care. David Plante has received publishing royalties from a publication relating to health care.
-
Author has nothing to disclose
-
Teresa Steininger has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Teresa Steininger has stock in Jazz Pharmaceuticals.
-
Mr. Fuller has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Mr. Fuller has stock in Jazz Pharmaceuticals.
-
Dr. Kirby has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Kirby has stock in Jazz Pharmaceuticals.
-
Dr. Akerman has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Akerman has stock in Jazz Pharmaceuticals.
-
Jessica K. Alexander has received personal compensation for serving as an employee of Teva Pharmaceuticals. Jessica K. Alexander has received stock or an ownership interest from Teva Pharmaceuticals.
-
Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Ruoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda . The institution of Dr. Ruoff has received research support from Jazz Pharmaceuticals. Dr. Ruoff has received personal compensation in the range of $10,000-$49,999 for serving as a lecturer with CME lectures .
-
Dr. Cairns has received personal compensation for serving as an employee of Bioserenity Research Group. Dr. Cairns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals.